US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SCYNEXIS Inc

1.00

+0.00800.81%

Post-market: 1.010.0100+1.00%19:45 EDT

Volume:606.41K

Turnover:607.16K

Market Cap:44.66M

PE:-5.80

High:1.05

Open:1.01

Low:0.9600

Close:0.9920

52wk High:1.31

52wk Low:0.5650

Shares:44.66M

Float Shares:37.98M

Volume Ratio:1.53

T/O Rate:1.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1724

EPS(LYR):-0.1724

ROE:-16.48%

ROA:-13.42%

PB:0.90

PE(LYR):-5.80

Loading ...

Overview Company News Filings

SCYNEXIS CEO David Angulo Gonzalez buys common shares for $0.1 million

SCYNEXIS buys PXL-770 asset from Poxel for USD 8 million upfront

SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease

MT Newswires Live

Poxel announces sale of PXL770 to Scynexis for up to $196M

Press Release: Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million

Scynexis Announces $40.0 Million Private Placement

THOMSON REUTERS

Scynexis Inc - Estimates Funds Will Support Operations Into Mid-2029

THOMSON REUTERS

Press Release: SCYNEXIS Announces $40.0 Million Private Placement

Scynexis Completes Transformative Acquisition of Pxl-770, an Innovative, Highly Selective, Direct Ampk Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (Adpkd)

THOMSON REUTERS

Scynexis Inc - to Pay $8 Mln Upfront, up to $188 Mln in Milestones for Acquisition

THOMSON REUTERS

Scynexis Inc - Phase 2 Study of Scy-770 in Adpkd to Begin in Q4 2026

THOMSON REUTERS

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Scynexis Reports Full Year 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS

Press Release: SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

SCYNEXIS posts FY 2025 license agreement revenue of USD 19.2 million up 411.4%

SCYNEXIS Doses First Participants in Phase 1 IV SCY-247 SAD/MAD Trial

Scynexis Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous Scy-247

THOMSON REUTERS

Scynexis Inc: Results From Phase 1 Trial Are Expected in 2026

THOMSON REUTERS

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCYX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCYX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCYX\",,,,,undefined,":{"symbol":"SCYX","market":"US","secType":"STK","nameCN":"SCYNEXIS Inc","latestPrice":1,"timestamp":1775851200000,"preClose":0.992,"halted":0,"volume":606414,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1,"latestTime":"19:45 EDT","volume":10101,"amount":10153.4513,"timestamp":1775864732775,"change":0.01,"changeRate":0.01,"amplitude":0.0101},"delay":0,"changeRate":0.008064516129032265,"floatShares":37982500,"shares":44663832,"eps":-0.172409,"marketStatus":"Market Closed","change":0.008,"latestTime":"04-10 16:00:00 EDT","open":1.01,"high":1.05,"low":0.96,"amount":607161.4658964,"amplitude":0.090726,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.172409,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1399003200000,"exchange":"NASDAQ","adjPreClose":0.992,"preHourTrading":{"tag":"盘前","latestPrice":0.987,"preClose":0.992,"latestTime":"09:28 EDT","volume":1084,"amount":1105.6102988,"timestamp":1775827705701,"change":-0.005,"changeRate":-0.00504,"amplitude":0.070766},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1,"latestTime":"19:45 EDT","volume":10101,"amount":10153.4513,"timestamp":1775864732775,"change":0.01,"changeRate":0.01,"amplitude":0.0101},"volumeRatio":1.5274708778411803,"impliedVol":3.0502,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCYX\",,,,,undefined,":{"symbol":"SCYX","floatShares":37982500,"roa":"-13.42%","roe":"-16.48%","lyrEps":-0.172409,"volumeRatio":1.5274708778411803,"shares":44663832,"dividePrice":0,"high":1.05,"amplitude":0.090726,"preClose":0.992,"low":0.96,"week52Low":0.565,"pbRate":"0.90","psRate":"2.17","week52High":1.31,"institutionHeld":0,"latestPrice":1,"eps":-0.172409,"divideRate":0,"volume":606414,"delay":0,"ttmEps":-0.172409,"open":1.01,"prevYearClose":0.6324,"prevWeekClose":0.8879,"prevMonthClose":0.9169,"prevQuarterClose":0.9169,"fiveDayClose":0.8879,"twentyDayClose":0.8903,"sixtyDayClose":0.6608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCYX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-04","symbol":"SCYX","fiscalQuarterEnding":"2025/12","expectedEps":0.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2025-11-05","symbol":"SCYX","fiscalQuarterEnding":"2025/09","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-08-13","symbol":"SCYX","fiscalQuarterEnding":"2025/06","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-05-15","symbol":"SCYX","fiscalQuarterEnding":"2025/03","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-03-12","symbol":"SCYX","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCYX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCYX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1715227200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCYX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCYX","date":"2026-04-09","current":-5.800161,"percent":0,"low":-5.167287,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"high":3.053916,"avg":-1.334859,"sd":1.511521,"marketCap":44485176},"quantilePoints":[{"date":"2021-04-16","current":-2.888721,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":159414073},{"date":"2021-04-23","current":-2.735503,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":150958734},{"date":"2021-04-30","current":-2.826284,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":155968470},{"date":"2021-05-07","current":-2.568329,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":141733252},{"date":"2021-05-14","current":-2.658053,"twenty":-3.195635,"median":-2.216835,"eighty":-1.65067,"marketCap":146684632},{"date":"2021-05-21","current":-3.360464,"twenty":-3.189491,"median":-2.216835,"eighty":-1.65067,"marketCap":177630757},{"date":"2021-05-28","current":-3.739053,"twenty":-3.189491,"median":-2.216835,"eighty":-1.65067,"marketCap":197642585},{"date":"2021-06-04","current":-3.137994,"twenty":-3.184089,"median":-2.216835,"eighty":-1.65067,"marketCap":165871230},{"date":"2021-06-11","current":-3.169218,"twenty":-3.180386,"median":-2.216835,"eighty":-1.65067,"marketCap":167521690},{"date":"2021-06-18","current":-2.927233,"twenty":-3.175433,"median":-2.216835,"eighty":-1.65067,"marketCap":154730625},{"date":"2021-06-25","current":-3.102867,"twenty":-3.170462,"median":-2.216835,"eighty":-1.65067,"marketCap":164014462},{"date":"2021-07-02","current":-3.079449,"twenty":-3.161457,"median":-2.216835,"eighty":-1.65067,"marketCap":162776617},{"date":"2021-07-09","current":-2.849174,"twenty":-3.150313,"median":-2.216835,"eighty":-1.65067,"marketCap":150604475},{"date":"2021-07-16","current":-2.618898,"twenty":-3.126691,"median":-2.216835,"eighty":-1.65067,"marketCap":138432332},{"date":"2021-07-23","current":-2.755502,"twenty":-3.118515,"median":-2.216835,"eighty":-1.65067,"marketCap":145653095},{"date":"2021-07-30","current":-2.720375,"twenty":-3.109416,"median":-2.216835,"eighty":-1.65067,"marketCap":143796327},{"date":"2021-08-06","current":-2.700861,"twenty":-3.100946,"median":-2.216835,"eighty":-1.65067,"marketCap":142764790},{"date":"2021-08-13","current":-2.443264,"twenty":-3.100946,"median":-2.223071,"eighty":-1.65067,"marketCap":129148495},{"date":"2021-08-20","current":-3.04081,"twenty":-3.105002,"median":-2.224141,"eighty":-1.65067,"marketCap":136289125},{"date":"2021-08-27","current":-3.315364,"twenty":-3.116329,"median":-2.224141,"eighty":-1.65067,"marketCap":148594617},{"date":"2021-09-03","current":-3.44487,"twenty":-3.125006,"median":-2.224141,"eighty":-1.65067,"marketCap":154399094},{"date":"2021-09-10","current":-3.496673,"twenty":-3.126691,"median":-2.224141,"eighty":-1.65067,"marketCap":156720885},{"date":"2021-09-17","current":-3.144416,"twenty":-3.126691,"median":-2.224141,"eighty":-1.65067,"marketCap":140932707},{"date":"2021-09-24","current":-2.890583,"twenty":-3.118515,"median":-2.224141,"eighty":-1.65067,"marketCap":129555932},{"date":"2021-10-01","current":-2.678193,"twenty":-3.109416,"median":-2.224141,"eighty":-1.65067,"marketCap":120036589},{"date":"2021-10-08","current":-2.662652,"twenty":-3.097415,"median":-2.224141,"eighty":-1.65067,"marketCap":119340052},{"date":"2021-10-15","current":-2.885403,"twenty":-3.086891,"median":-2.224141,"eighty":-1.65067,"marketCap":129323753},{"date":"2021-10-22","current":-2.683373,"twenty":-3.078621,"median":-2.224141,"eighty":-1.65067,"marketCap":120268768},{"date":"2021-10-29","current":-2.595308,"twenty":-3.0724,"median":-2.224141,"eighty":-1.65067,"marketCap":116321724},{"date":"2021-11-05","current":-2.916484,"twenty":-3.060574,"median":-2.224141,"eighty":-1.65067,"marketCap":130716827},{"date":"2021-11-12","current":-2.791269,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":129330653},{"date":"2021-11-19","current":-3.685509,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":170764362},{"date":"2021-11-26","current":-3.840579,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":177949399},{"date":"2021-12-03","current":-3.463068,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":160457771},{"date":"2021-12-10","current":-3.881024,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":179823365},{"date":"2021-12-17","current":-3.832172,"twenty":-3.069246,"median":-2.224141,"eighty":-1.65067,"marketCap":177559854},{"date":"2021-12-23","current":-4.15485,"twenty":-3.077756,"median":-2.224141,"eighty":-1.65067,"marketCap":192510816},{"date":"2021-12-31","current":-3.754753,"twenty":-3.08102,"median":-2.224141,"eighty":-1.65067,"marketCap":173972738},{"date":"2022-01-07","current":-3.896326,"twenty":-3.094419,"median":-2.225543,"eighty":-1.65067,"marketCap":180532365},{"date":"2022-01-14","current":-3.723977,"twenty":-3.109903,"median":-2.225543,"eighty":-1.65067,"marketCap":172546732},{"date":"2022-01-21","current":-3.04689,"twenty":-3.113285,"median":-2.225543,"eighty":-1.65067,"marketCap":141174598},{"date":"2022-01-28","current":-2.837609,"twenty":-3.113285,"median":-2.225543,"eighty":-1.65067,"marketCap":131477757},{"date":"2022-02-04","current":-2.831453,"twenty":-3.11599,"median":-2.225543,"eighty":-1.65067,"marketCap":131192556},{"date":"2022-02-11","current":-2.960715,"twenty":-3.122736,"median":-2.225543,"eighty":-1.65067,"marketCap":137181782},{"date":"2022-02-18","current":-2.720657,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":126058934},{"date":"2022-02-25","current":-2.591395,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":120069709},{"date":"2022-03-04","current":-2.382114,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":110372868},{"date":"2022-03-11","current":-2.443667,"twenty":-3.118352,"median":-2.230097,"eighty":-1.65067,"marketCap":113224880},{"date":"2022-03-18","current":-3.108443,"twenty":-3.118352,"median":-2.230097,"eighty":-1.65067,"marketCap":144026611},{"date":"2022-03-25","current":-2.966871,"twenty":-3.118352,"median":-2.240172,"eighty":-1.65067,"marketCap":137466983},{"date":"2022-04-01","current":-3.408068,"twenty":-3.128627,"median":-2.246144,"eighty":-1.65067,"marketCap":112009557},{"date":"2022-04-08","current":-3.161489,"twenty":-3.150313,"median":-2.257272,"eighty":-1.65067,"marketCap":103905506},{"date":"2022-04-14","current":-2.950136,"twenty":-3.150313,"median":-2.27274,"eighty":-1.65067,"marketCap":96959177},{"date":"2022-04-22","current":-2.288199,"twenty":-3.150313,"median":-2.282474,"eighty":-1.65067,"marketCap":75203944},{"date":"2022-04-29","current":-2.622099,"twenty":-3.150313,"median":-2.290881,"eighty":-1.65067,"marketCap":86177910},{"date":"2022-05-06","current":-2.220473,"twenty":-3.150313,"median":-2.296896,"eighty":-1.65067,"marketCap":72978059},{"date":"2022-05-13","current":-2.004683,"twenty":-3.150313,"median":-2.296896,"eighty":-1.658123,"marketCap":67439546},{"date":"2022-05-20","current":-2.053105,"twenty":-3.150313,"median":-2.296896,"eighty":-1.667779,"marketCap":69068520},{"date":"2022-05-27","current":-1.994999,"twenty":-3.150313,"median":-2.296896,"eighty":-1.675332,"marketCap":67113751},{"date":"2022-06-03","current":-2.024052,"twenty":-3.150313,"median":-2.296896,"eighty":-1.679008,"marketCap":68091136},{"date":"2022-06-10","current":-1.88847,"twenty":-3.150313,"median":-2.296896,"eighty":-1.69591,"marketCap":63530007},{"date":"2022-06-17","current":-1.723834,"twenty":-3.150313,"median":-2.296896,"eighty":-1.715251,"marketCap":57991493},{"date":"2022-06-24","current":-1.994999,"twenty":-3.150313,"median":-2.298884,"eighty":-1.721944,"marketCap":67113751},{"date":"2022-07-01","current":-1.810994,"twenty":-3.150313,"median":-2.298884,"eighty":-1.72802,"marketCap":60923648},{"date":"2022-07-08","current":-1.907839,"twenty":-3.150313,"median":-2.298884,"eighty":-1.740985,"marketCap":64181597},{"date":"2022-07-15","current":-1.994999,"twenty":-3.150313,"median":-2.298884,"eighty":-1.751618,"marketCap":67113751},{"date":"2022-07-22","current":-2.120897,"twenty":-3.150313,"median":-2.298884,"eighty":-1.761561,"marketCap":71349085},{"date":"2022-07-29","current":-2.23711,"twenty":-3.150313,"median":-2.298884,"eighty":-1.775155,"marketCap":75258624},{"date":"2022-08-05","current":-2.769755,"twenty":-3.150313,"median":-2.307215,"eighty":-1.781941,"marketCap":93177344},{"date":"2022-08-12","current":-2.785692,"twenty":-3.150313,"median":-2.320867,"eighty":-1.800361,"marketCap":93713472},{"date":"2022-08-19","current":-1.839196,"twenty":-3.150313,"median":-2.320867,"eighty":-1.804979,"marketCap":89465871},{"date":"2022-08-26","current":-1.684811,"twenty":-3.150313,"median":-2.320867,"eighty":-1.8075,"marketCap":81955962},{"date":"2022-09-02","current":-1.637825,"twenty":-3.150313,"median":-2.320867,"eighty":-1.8075,"marketCap":79670338},{"date":"2022-09-09","current":-1.704949,"twenty":-3.150313,"median":-2.320867,"eighty":-1.805621,"marketCap":82935516},{"date":"2022-09-16","current":-1.953307,"twenty":-3.150313,"median":-2.320867,"eighty":-1.810687,"marketCap":95016673},{"date":"2022-09-23","current":-1.584125,"twenty":-3.150313,"median":-2.320867,"eighty":-1.805621,"marketCap":77058196},{"date":"2022-09-30","current":-1.610975,"twenty":-3.150313,"median":-2.320867,"eighty":-1.80131,"marketCap":78364267},{"date":"2022-10-07","current":-1.738511,"twenty":-3.150313,"median":-2.320867,"eighty":-1.783124,"marketCap":84568105},{"date":"2022-10-14","current":-1.845909,"twenty":-3.150313,"median":-2.320867,"eighty":-1.781941,"marketCap":89792389},{"date":"2022-10-21","current":-1.604263,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":78037749},{"date":"2022-10-28","current":-1.6244,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":79017302},{"date":"2022-11-04","current":-1.496864,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":72813464},{"date":"2022-11-11","current":-0.828804,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":64334274},{"date":"2022-11-18","current":-0.955018,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":74131371},{"date":"2022-11-25","current":-1.030746,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":80009630},{"date":"2022-12-02","current":-0.96764,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":75111081},{"date":"2022-12-09","current":-0.891911,"twenty":-3.150313,"median":-2.320867,"eighty":-1.783124,"marketCap":69232823},{"date":"2022-12-16","current":-0.807769,"twenty":-3.150313,"median":-2.320867,"eighty":-1.772983,"marketCap":62701424},{"date":"2022-12-23","current":-0.656312,"twenty":-3.150313,"median":-2.320867,"eighty":-1.753201,"marketCap":50944907},{"date":"2022-12-30","current":-0.656312,"twenty":-3.150313,"median":-2.320867,"eighty":-1.74912,"marketCap":50944907},{"date":"2023-01-06","current":-0.694176,"twenty":-3.1448,"median":-2.315558,"eighty":-1.739044,"marketCap":53884036},{"date":"2023-01-13","current":-0.79094,"twenty":-3.1448,"median":-2.299164,"eighty":-1.737737,"marketCap":61395144},{"date":"2023-01-20","current":-0.706798,"twenty":-3.1448,"median":-2.293985,"eighty":-1.722893,"marketCap":54863746},{"date":"2023-01-27","current":-0.73204,"twenty":-3.1448,"median":-2.283629,"eighty":-1.715084,"marketCap":56823166},{"date":"2023-02-03","current":-0.706798,"twenty":-3.1448,"median":-2.273131,"eighty":-1.711661,"marketCap":54863746},{"date":"2023-02-10","current":-0.664726,"twenty":-3.1448,"median":-2.258737,"eighty":-1.698236,"marketCap":51598047},{"date":"2023-02-17","current":-0.643691,"twenty":-3.1448,"median":-2.24967,"eighty":-1.68771,"marketCap":49965197},{"date":"2023-02-24","current":-0.614241,"twenty":-3.1448,"median":-2.243009,"eighty":-1.678099,"marketCap":47679208},{"date":"2023-03-03","current":-0.740455,"twenty":-3.1448,"median":-2.240172,"eighty":-1.672419,"marketCap":57476305},{"date":"2023-03-10","current":-0.559548,"twenty":-3.130969,"median":-2.226946,"eighty":-1.660764,"marketCap":43433799},{"date":"2023-03-17","current":-0.48382,"twenty":-3.126285,"median":-2.217921,"eighty":-1.651249,"marketCap":37555540},{"date":"2023-03-24","current":-0.786733,"twenty":-3.126285,"median":-2.207748,"eighty":-1.641348,"marketCap":61068575},{"date":"2023-03-31","current":-1.591689,"twenty":-3.126285,"median":-2.205971,"eighty":-1.634541,"marketCap":99972393},{"date":"2023-04-06","current":-1.888804,"twenty":-3.126285,"median":-2.205717,"eighty":-1.631112,"marketCap":118633906},{"date":"2023-04-14","current":-1.607606,"twenty":-3.126285,"median":-2.18887,"eighty":-1.630145,"marketCap":100972116},{"date":"2023-04-21","current":-1.665968,"twenty":-3.126285,"median":-2.188551,"eighty":-1.630145,"marketCap":104637771},{"date":"2023-04-28","current":-1.623523,"twenty":-3.126285,"median":-2.178151,"eighty":-1.624324,"marketCap":101971840},{"date":"2023-05-05","current":-1.761656,"twenty":-3.126285,"median":-2.154669,"eighty":-1.624324,"marketCap":110647849},{"date":"2023-05-12","current":-1.100719,"twenty":-3.126285,"median":-2.151175,"eighty":-1.622994,"marketCap":100422965},{"date":"2023-05-19","current":-1.14875,"twenty":-3.125433,"median":-2.14185,"eighty":-1.612288,"marketCap":104805058},{"date":"2023-05-26","current":-1.062694,"twenty":-3.116667,"median":-2.137172,"eighty":-1.605294,"marketCap":96953808},{"date":"2023-06-02","current":-1.048685,"twenty":-3.099745,"median":-2.130957,"eighty":-1.602142,"marketCap":95675698},{"date":"2023-06-09","current":-1.036677,"twenty":-3.082073,"median":-2.130957,"eighty":-1.591689,"marketCap":94580174},{"date":"2023-06-16","current":-1.096716,"twenty":-3.06982,"median":-2.125104,"eighty":-1.582484,"marketCap":100057791},{"date":"2023-06-23","current":-1.116729,"twenty":-3.04689,"median":-2.111759,"eighty":-1.571504,"marketCap":101883663},{"date":"2023-06-30","current":-1.208789,"twenty":-3.030346,"median":-2.111759,"eighty":-1.570245,"marketCap":110282674},{"date":"2023-07-07","current":-1.14875,"twenty":-3.009132,"median":-2.111759,"eighty":-1.56344,"marketCap":104805058},{"date":"2023-07-14","current":-1.096716,"twenty":-2.994168,"median":-2.105564,"eighty":-1.552469,"marketCap":100057791},{"date":"2023-07-21","current":-1.188776,"twenty":-2.977539,"median":-2.097437,"eighty":-1.540618,"marketCap":108456802},{"date":"2023-07-28","current":-1.124734,"twenty":-2.966385,"median":-2.092561,"eighty":-1.529197,"marketCap":102614012},{"date":"2023-08-04","current":-1.152753,"twenty":-2.955233,"median":-2.086267,"eighty":-1.527736,"marketCap":105170232},{"date":"2023-08-11","current":-1.196781,"twenty":-2.955233,"median":-2.077442,"eighty":-1.516984,"marketCap":109187151},{"date":"2023-08-18","current":2.320808,"twenty":-2.955233,"median":-2.073364,"eighty":-1.508165,"marketCap":102976592},{"date":"2023-08-25","current":2.588916,"twenty":-2.955233,"median":-2.073364,"eighty":-1.501484,"marketCap":114872804},{"date":"2023-09-01","current":2.949186,"twenty":-2.955233,"median":-2.073364,"eighty":-1.496259,"marketCap":130858340},{"date":"2023-09-08","current":2.647565,"twenty":-2.955233,"median":-2.073364,"eighty":-1.484058,"marketCap":117475101},{"date":"2023-09-15","current":2.840267,"twenty":-2.955233,"median":-2.073364,"eighty":-1.480436,"marketCap":126025504},{"date":"2023-09-22","current":2.848646,"twenty":-2.955233,"median":-2.073364,"eighty":-1.457662,"marketCap":126397261},{"date":"2023-09-29","current":1.927025,"twenty":-2.955233,"median":-2.073364,"eighty":-1.435218,"marketCap":85504029},{"date":"2023-10-06","current":1.876755,"twenty":-2.955233,"median":-2.073364,"eighty":-1.400777,"marketCap":83273489},{"date":"2023-10-13","current":1.675674,"twenty":-2.955233,"median":-2.073364,"eighty":-1.384901,"marketCap":74351330},{"date":"2023-10-20","current":1.675674,"twenty":-2.955233,"median":-2.073364,"eighty":-1.356336,"marketCap":74351330},{"date":"2023-10-27","current":1.432701,"twenty":-2.957253,"median":-2.073364,"eighty":-1.340811,"marketCap":63570387},{"date":"2023-11-03","current":1.508107,"twenty":-2.957253,"median":-2.073364,"eighty":-1.330152,"marketCap":66916197},{"date":"2023-11-10","current":1.415944,"twenty":-2.957253,"median":-2.073364,"eighty":-1.317564,"marketCap":62826873},{"date":"2023-11-17","current":0.814265,"twenty":-2.957253,"median":-2.073364,"eighty":-1.294712,"marketCap":58788322},{"date":"2023-11-24","current":0.855494,"twenty":-2.957253,"median":-2.073364,"eighty":-1.244813,"marketCap":61764946},{"date":"2023-12-01","current":0.865801,"twenty":-2.957253,"median":-2.073364,"eighty":-1.207188,"marketCap":62509102},{"date":"2023-12-08","current":0.876108,"twenty":-2.95658,"median":-2.073364,"eighty":-1.196781,"marketCap":63253258},{"date":"2023-12-15","current":0.855494,"twenty":-2.95658,"median":-2.073364,"eighty":-1.190278,"marketCap":61764946},{"date":"2023-12-22","current":0.963719,"twenty":-2.95658,"median":-2.073364,"eighty":-1.190278,"marketCap":69578584},{"date":"2023-12-29","current":1.118326,"twenty":-2.957253,"median":-2.073364,"eighty":-1.193382,"marketCap":80740923},{"date":"2024-01-05","current":0.999794,"twenty":-2.957926,"median":-2.073364,"eighty":-1.188776,"marketCap":72183130},{"date":"2024-01-12","current":1.030716,"twenty":-2.957926,"median":-2.073364,"eighty":-1.172766,"marketCap":74415598},{"date":"2024-01-19","current":0.974026,"twenty":-2.958484,"median":-2.073364,"eighty":-1.166361,"marketCap":70322740},{"date":"2024-01-26","current":0.932798,"twenty":-2.957926,"median":-2.073364,"eighty":-1.14875,"marketCap":67346116},{"date":"2024-02-02","current":1.087405,"twenty":-2.957926,"median":-2.073364,"eighty":-1.13274,"marketCap":78508455},{"date":"2024-02-09","current":0.989487,"twenty":-2.957926,"median":-2.064896,"eighty":-1.124734,"marketCap":71438974},{"date":"2024-02-16","current":0.917337,"twenty":-2.952746,"median":-2.054166,"eighty":-1.116729,"marketCap":66229882},{"date":"2024-02-23","current":0.85034,"twenty":-2.947566,"median":-2.054166,"eighty":-1.108724,"marketCap":61392868},{"date":"2024-03-01","current":0.83488,"twenty":-2.945841,"median":-2.049856,"eighty":-1.101519,"marketCap":60276634},{"date":"2024-03-08","current":0.870955,"twenty":-2.945841,"median":-2.036863,"eighty":-1.092713,"marketCap":62881180},{"date":"2024-03-15","current":0.773037,"twenty":-2.938942,"median":-2.028894,"eighty":-1.064615,"marketCap":55811698},{"date":"2024-03-22","current":0.721501,"twenty":-2.924541,"median":-2.01577,"eighty":-1.038857,"marketCap":52090918},{"date":"2024-03-28","current":0.734385,"twenty":-2.913921,"median":-2.005766,"eighty":-1.030746,"marketCap":53021113},{"date":"2024-04-05","current":0.946076,"twenty":-2.893007,"median":-2.000764,"eighty":-0.99757,"marketCap":63425848},{"date":"2024-04-12","current":0.901024,"twenty":-2.885403,"median":-1.996572,"eighty":-0.955018,"marketCap":60405569},{"date":"2024-04-19","current":0.791212,"twenty":-2.874541,"median":-1.991971,"eighty":-0.891911,"marketCap":53043640},{"date":"2024-04-26","current":0.828393,"twenty":-2.867482,"median":-1.976503,"eighty":-0.84984,"marketCap":55536300},{"date":"2024-05-03","current":1.003088,"twenty":-2.855419,"median":-1.966732,"eighty":-0.810293,"marketCap":67248036},{"date":"2024-05-10","current":0.700952,"twenty":-2.849141,"median":-1.962718,"eighty":-0.774953,"marketCap":71026016},{"date":"2024-05-17","current":0.89856,"twenty":-2.849141,"median":-1.954211,"eighty":-0.765697,"marketCap":91049308},{"date":"2024-05-24","current":0.835176,"twenty":-2.849141,"median":-1.949462,"eighty":-0.751393,"marketCap":84626743},{"date":"2024-05-31","current":0.876189,"twenty":-2.849141,"median":-1.938177,"eighty":-0.732881,"marketCap":88782520},{"date":"2024-06-07","current":0.853819,"twenty":-2.849141,"median":-1.926115,"eighty":-0.727833,"marketCap":86515732},{"date":"2024-06-14","current":0.794163,"twenty":-2.849141,"median":-1.92281,"eighty":-0.715212,"marketCap":80470965},{"date":"2024-06-21","current":0.700952,"twenty":-2.849148,"median":-1.912893,"eighty":-0.710164,"marketCap":71026016},{"date":"2024-06-28","current":0.756879,"twenty":-2.849167,"median":-1.907839,"eighty":-0.703432,"marketCap":76692985},{"date":"2024-07-05","current":0.723322,"twenty":-2.849167,"median":-1.898161,"eighty":-0.689969,"marketCap":73292804},{"date":"2024-07-12","current":0.827719,"twenty":-2.849167,"median":-1.88847,"eighty":-0.668933,"marketCap":83871147},{"date":"2024-07-15","current":0.820262,"twenty":-2.849167,"median":-1.887585,"eighty":-0.665567,"marketCap":83115551},{"date":"2024-08-02","current":0.760607,"twenty":-2.85698,"median":-1.871593,"eighty":-0.657574,"marketCap":77070783},{"date":"2024-08-09","current":-2.043115,"twenty":-2.85698,"median":-1.868342,"eighty":-0.652105,"marketCap":72305844},{"date":"2024-08-16","current":-1.85057,"twenty":-2.85698,"median":-1.866147,"eighty":-0.652105,"marketCap":65491680},{"date":"2024-08-23","current":-1.797086,"twenty":-2.85698,"median":-1.859416,"eighty":-0.652105,"marketCap":63598857},{"date":"2024-08-30","current":-1.561753,"twenty":-2.85698,"median":-1.85057,"eighty":-0.652105,"marketCap":55270435},{"date":"2024-09-06","current":-1.43339,"twenty":-2.85698,"median":-1.849885,"eighty":-0.652105,"marketCap":50727660},{"date":"2024-09-13","current":-1.43339,"twenty":-2.85698,"median":-1.84055,"eighty":-0.652105,"marketCap":50727660},{"date":"2024-09-20","current":-1.743601,"twenty":-2.85698,"median":-1.82622,"eighty":-0.652105,"marketCap":61706034},{"date":"2024-09-27","current":-1.615238,"twenty":-2.85698,"median":-1.819059,"eighty":-0.652105,"marketCap":57163259},{"date":"2024-10-04","current":-1.508268,"twenty":-2.85698,"median":-1.813763,"eighty":-0.652105,"marketCap":53377612},{"date":"2024-10-11","current":-1.625935,"twenty":-2.85698,"median":-1.809485,"eighty":-0.652105,"marketCap":57541823},{"date":"2024-10-18","current":-1.615238,"twenty":-2.85698,"median":-1.802935,"eighty":-0.652105,"marketCap":57163259},{"date":"2024-10-25","current":-1.551056,"twenty":-2.85698,"median":-1.798004,"eighty":-0.652105,"marketCap":54891871},{"date":"2024-10-31","current":-1.444087,"twenty":-2.85698,"median":-1.779714,"eighty":-0.652105,"marketCap":51106225},{"date":"2024-11-08","current":-1.384828,"twenty":-2.85698,"median":-1.772256,"eighty":-0.652105,"marketCap":50464510},{"date":"2024-11-15","current":-1.311942,"twenty":-2.85698,"median":-1.753854,"eighty":-0.652105,"marketCap":47808483},{"date":"2024-11-22","current":-1.239244,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":45159299},{"date":"2024-11-29","current":-1.426693,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":51990117},{"date":"2024-12-06","current":-1.244451,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":45349044},{"date":"2024-12-13","current":-1.155934,"twenty":-2.85698,"median":-1.745046,"eighty":-0.652105,"marketCap":42123380},{"date":"2024-12-20","current":-1.051796,"twenty":-2.85698,"median":-1.738511,"eighty":-0.652105,"marketCap":38328480},{"date":"2024-12-27","current":-1.062209,"twenty":-2.85698,"median":-1.7384,"eighty":-0.652105,"marketCap":38707970},{"date":"2025-01-03","current":-1.510003,"twenty":-2.85698,"median":-1.723834,"eighty":-0.652105,"marketCap":55026036},{"date":"2025-01-10","current":-1.280899,"twenty":-2.85698,"median":-1.715,"eighty":-0.652105,"marketCap":46677258},{"date":"2025-01-17","current":-1.187175,"twenty":-2.85698,"median":-1.711585,"eighty":-0.652105,"marketCap":43261849},{"date":"2025-01-24","current":-1.124692,"twenty":-2.85698,"median":-1.702881,"eighty":-0.652105,"marketCap":40984910},{"date":"2025-01-31","current":-1.14552,"twenty":-2.85698,"median":-1.688654,"eighty":-0.652105,"marketCap":41743890},{"date":"2025-02-07","current":-1.208003,"twenty":-2.85698,"median":-1.678759,"eighty":-0.652105,"marketCap":44020829},{"date":"2025-02-14","current":-1.218417,"twenty":-2.85698,"median":-1.670993,"eighty":-0.652105,"marketCap":44400319},{"date":"2025-02-21","current":-1.150727,"twenty":-2.849174,"median":-1.665968,"eighty":-0.652105,"marketCap":41933635},{"date":"2025-02-28","current":-1.037216,"twenty":-2.849167,"median":-1.651249,"eighty":-0.652105,"marketCap":37797195},{"date":"2025-03-07","current":-0.999726,"twenty":-2.849174,"median":-1.641351,"eighty":-0.652105,"marketCap":36431031},{"date":"2025-03-14","current":-1.530046,"twenty":-2.849174,"median":-1.637825,"eighty":-0.652105,"marketCap":32571618},{"date":"2025-03-21","current":-1.904374,"twenty":-2.849174,"median":-1.647328,"eighty":-0.652105,"marketCap":40540306},{"date":"2025-03-28","current":-1.84944,"twenty":-2.849174,"median":-1.661427,"eighty":-0.652105,"marketCap":39370874},{"date":"2025-04-04","current":-1.649114,"twenty":-2.849174,"median":-1.665968,"eighty":-0.652105,"marketCap":35106346},{"date":"2025-04-11","current":-1.604435,"twenty":-2.849167,"median":-1.665968,"eighty":-0.652105,"marketCap":34155208},{"date":"2025-04-17","current":-1.671088,"twenty":-2.849167,"median":-1.66551,"eighty":-0.652105,"marketCap":35574119},{"date":"2025-04-25","current":-1.950152,"twenty":-2.849174,"median":-1.668722,"eighty":-0.652105,"marketCap":41514833},{"date":"2025-05-02","current":-1.798351,"twenty":-2.849174,"median":-1.670213,"eighty":-0.652105,"marketCap":38283302},{"date":"2025-05-09","current":-1.752939,"twenty":-2.849174,"median":-1.67768,"eighty":-0.652105,"marketCap":37316572},{"date":"2025-05-16","current":-1.792309,"twenty":-2.849174,"median":-1.67768,"eighty":-0.652105,"marketCap":38154665},{"date":"2025-05-23","current":-1.107845,"twenty":-2.849174,"median":-1.668722,"eighty":-0.652105,"marketCap":30011521},{"date":"2025-05-30","current":-1.28685,"twenty":-2.849174,"median":-1.662372,"eighty":-0.652105,"marketCap":34860765},{"date":"2025-06-06","current":-1.275757,"twenty":-2.849174,"median":-1.649114,"eighty":-0.652105,"marketCap":34560256},{"date":"2025-06-13","current":-1.184004,"twenty":-2.849174,"median":-1.637825,"eighty":-0.652105,"marketCap":32074665},{"date":"2025-06-20","current":-1.072373,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":29050593},{"date":"2025-06-27","current":-1.06085,"twenty":-2.849174,"median":-1.627717,"eighty":-0.651264,"marketCap":28738431},{"date":"2025-07-03","current":-1.053504,"twenty":-2.849174,"median":-1.623082,"eighty":-0.651264,"marketCap":28539428},{"date":"2025-07-11","current":-1.008276,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":27314191},{"date":"2025-07-18","current":-1.065892,"twenty":-2.849174,"median":-1.598124,"eighty":-0.651264,"marketCap":28875002},{"date":"2025-07-25","current":-1.063011,"twenty":-2.849174,"median":-1.593463,"eighty":-0.651264,"marketCap":28796962},{"date":"2025-08-01","current":-0.994016,"twenty":-2.849174,"median":-1.584592,"eighty":-0.651264,"marketCap":26927891},{"date":"2025-08-08","current":-1.260345,"twenty":-2.849174,"median":-1.580614,"eighty":-0.651264,"marketCap":34142739},{"date":"2025-08-15","current":-1.721936,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":33607032},{"date":"2025-08-22","current":-1.749218,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":34139479},{"date":"2025-08-29","current":-1.825476,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":35627814},{"date":"2025-09-05","current":-1.866505,"twenty":-2.849174,"median":-1.576968,"eighty":-0.650422,"marketCap":36428581},{"date":"2025-09-12","current":-2.534787,"twenty":-2.849174,"median":-1.583636,"eighty":-0.651264,"marketCap":49471430},{"date":"2025-09-19","current":-2.341455,"twenty":-2.849174,"median":-1.593463,"eighty":-0.651264,"marketCap":45698185},{"date":"2025-09-26","current":-2.319974,"twenty":-2.849174,"median":-1.598124,"eighty":-0.651264,"marketCap":45278936},{"date":"2025-10-03","current":-1.710551,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":33384830},{"date":"2025-10-10","current":-1.700455,"twenty":-2.849174,"median":-1.615238,"eighty":-0.651264,"marketCap":33187783},{"date":"2025-10-17","current":-1.718499,"twenty":-2.849174,"median":-1.628524,"eighty":-0.651264,"marketCap":33539952},{"date":"2025-10-24","current":-1.654056,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":32282204},{"date":"2025-10-31","current":-1.475761,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":28802434},{"date":"2025-11-07","current":-0.988302,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":25004034},{"date":"2025-11-14","current":-0.978798,"twenty":-2.849174,"median":-1.625935,"eighty":-0.651264,"marketCap":24763580},{"date":"2025-11-21","current":-1.144502,"twenty":-2.849174,"median":-1.616388,"eighty":-0.651264,"marketCap":28955890},{"date":"2025-11-28","current":-1.144667,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":28960086},{"date":"2025-12-05","current":-1.109669,"twenty":-2.849174,"median":-1.598072,"eighty":-0.651264,"marketCap":28074623},{"date":"2025-12-12","current":-1.069528,"twenty":-2.83878,"median":-1.592386,"eighty":-0.651264,"marketCap":27059069},{"date":"2025-12-19","current":-1.045809,"twenty":-2.827318,"median":-1.583147,"eighty":-0.651264,"marketCap":26458969},{"date":"2025-12-26","current":-0.987091,"twenty":-2.819962,"median":-1.57245,"eighty":-0.651264,"marketCap":24973406},{"date":"2026-01-02","current":-1.048961,"twenty":-2.809035,"median":-1.570701,"eighty":-0.651264,"marketCap":26538702},{"date":"2026-01-09","current":-1.104029,"twenty":-2.790757,"median":-1.561753,"eighty":-0.651264,"marketCap":27931942},{"date":"2026-01-16","current":-1.06505,"twenty":-2.777078,"median":-1.539254,"eighty":-0.651264,"marketCap":26945763},{"date":"2026-01-23","current":-1.25381,"twenty":-2.766957,"median":-1.529662,"eighty":-0.651264,"marketCap":31721387},{"date":"2026-01-30","current":-1.228266,"twenty":-2.752248,"median":-1.507534,"eighty":-0.651264,"marketCap":31075125},{"date":"2026-02-06","current":-1.145165,"twenty":-2.740507,"median":-1.497218,"eighty":-0.651264,"marketCap":28972676},{"date":"2026-02-13","current":-1.288974,"twenty":-2.72134,"median":-1.478689,"eighty":-0.651264,"marketCap":32611046},{"date":"2026-02-20","current":-1.345536,"twenty":-2.717381,"median":-1.470562,"eighty":-0.651264,"marketCap":34042055},{"date":"2026-02-27","current":-1.169382,"twenty":-2.696422,"median":-1.43339,"eighty":-0.651264,"marketCap":29585365},{"date":"2026-03-06","current":-3.863086,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":33257308},{"date":"2026-03-13","current":-4.618911,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":39764209},{"date":"2026-03-20","current":-4.638107,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":39929465},{"date":"2026-03-27","current":-4.344983,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":37405959},{"date":"2026-04-02","current":-4.608535,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":39674881},{"date":"2026-04-09","current":-5.167287,"twenty":-2.683373,"median":-1.426693,"eighty":-0.651264,"marketCap":44485176}],"updateTime":1775867174964},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCYX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624450660","title":"SCYNEXIS CEO David Angulo Gonzalez buys common shares for $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624450660","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624450660?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:02","pubTimestamp":1775131365,"startTime":"0","endTime":"0","summary":"SCYNEXIS Chief Executive Officer David Angulo Gonzalez reported purchase of 108,695 common shares.Filing shows direct beneficial ownership rose to 1,357,126 common shares.Report also discloses purchase of warrants for 108,695 common shares with an exercise price of $1.2 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SCYNEXIS Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDLbB7J0j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"SCYNEXIS CEO David Angulo Gonzalez buys common shares for $0.1 million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553971","title":"SCYNEXIS buys PXL-770 asset from Poxel for USD 8 million upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553971","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553971?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:16","pubTimestamp":1774991809,"startTime":"0","endTime":"0","summary":"SCYNEXIS agreed to acquire PXL-770, now renamed SCY-770, from Poxel.Deal terms include USD 8 million upfront consideration.Milestones total up to USD 190 million, including up to USD 180 million tied to commercial targets.SCYNEXIS expects to start Phase 2 proof-of-concept study in ADPKD in Q4 2026.Early efficacy readout targeted for second half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8YfjP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2210150020.SGD","BK4585","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2W23.USD","BK4588","IE00BGHQF748.EUR","SCYX","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4007","LU0314104364.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623862675","title":"SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2623862675","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623862675?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:59","pubTimestamp":1774958340,"startTime":"0","endTime":"0","summary":"SCYNEXIS  said Tuesday that it has entered into a securities purchase agreement with investors for a private placement that is expected to raise gross proceeds of about $40 million.The company will issue about 34.8 million of its common shares, pre-funded warrants to buy up to about 8.8 million common shares and accompanying common warrants to buy up to 43.5 million common shares.The company expects up to an additional $52.2 million in gross proceeds if the common warrants are fully exercised for cash.The private placement is expected to close on or about Wednesday. The company said it plans to use the net proceeds for working capital and general corporate purposes.SCYNEXIS separately said Tuesday that it entered into a definitive agreement with Poxel to acquire PXL-770 and renamed it SCY-770.SCY-770 is an oral therapy used for the treatment of autosomal dominant polycystic kidney disease, for which a phase 2 proof-of-concept study is expected to start in Q4.The company's shares were u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623585396","title":"Poxel announces sale of PXL770 to Scynexis for up to $196M","url":"https://stock-news.laohu8.com/highlight/detail?id=2623585396","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623585396?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:20","pubTimestamp":1774956057,"startTime":"0","endTime":"0","summary":"POXEL (PXXLF) entered into a definitive agreement with SCYNEXIS (SCYX) in connection with the sale of its drug candidate PXL770. PXL-770 is a novel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/poxel-announces-sale-of-pxl770-to-scynexis-for-up-to-196m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/poxel-announces-sale-of-pxl770-to-scynexis-for-up-to-196m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","PXXLF","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623583111","title":"Press Release: Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583111","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623583111?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:07","pubTimestamp":1774955220,"startTime":"0","endTime":"0","summary":"--  PXL770, a first-in-class direct activator of adenosine. monophosphate-activated protein kinase , is a clinical-stage drug. candidate targeting the underlying mechanisms of autosomal dominant. polycystic kidney disease  by reducing cyst growth and disease. --  Poxel will receive an upfront payment of $8 million, with an additional. short-term payment of up to $8 million related to development milestones,--  A Phase 2 proof-of-concept study in patients with ADPKD is expected to. PXL-770 is a novel, highly selective, direct AMPK activator developed for the treatment of autosomal dominant polycystic kidney disease , the leading genetic cause of end-stage renal disease. This product has been designed to act on several underlying mechanisms of ADPKD by reducing cyst growth and disease progression. PXL770 has been granted orphan drug designation by the U.S. Food and Drug Administration  and is protected by existing patents until at least 2041 . To date, ADPKD has only one approved treatme","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4007","BK4232","SCYX","ALD","R","TSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623884725","title":"Scynexis Announces $40.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623884725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623884725?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:45","pubTimestamp":1774953900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7YZKKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623588718","title":"Scynexis Inc - Estimates Funds Will Support Operations Into Mid-2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2623588718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623588718?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:45","pubTimestamp":1774953900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7YZKKY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623588282","title":"Press Release: SCYNEXIS Announces $40.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623588282","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623588282?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:45","pubTimestamp":1774953900,"startTime":"0","endTime":"0","summary":"JERSEY CITY, N.J., March 31, 2026  -- SCYNEXIS, Inc.  , a biotechnology company focused on developing innovative new therapies to address severe rare diseases including SCY-770 for Autosomal Dominant Polycystic Kidney Disease , today announced that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors. The Company anticipates upfront gross proceeds from the private placement to be approximately $40.0 million, before deducting placement agent fees and transaction-related expenses, and up to an additional $52.2 million in gross proceeds if the Common Warrants are fully exercised for cash, subject to Stockholder Approval of shares of common stock issuable upon exercise of the Common Warrants. The private placement is expected to close on or about April 1, 2026, subject to the satisfaction of customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4007","R","SCYX","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623658588","title":"Scynexis Completes Transformative Acquisition of Pxl-770, an Innovative, Highly Selective, Direct Ampk Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (Adpkd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623658588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623658588?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7CMTF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623588926","title":"Scynexis Inc - to Pay $8 Mln Upfront, up to $188 Mln in Milestones for Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2623588926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623588926?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7CMTF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623588116","title":"Scynexis Inc - Phase 2 Study of Scy-770 in Adpkd to Begin in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623588116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623588116?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7CMTF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623258553","title":"SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623258553","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623258553?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953600,"startTime":"0","endTime":"0","summary":"PXL-770 (now SCY-770) is a clinical stage, well-characterized oral therapy designed to address the underlying drivers of ADPKD by reducing cyst growth and disease progressionA Phase 2 proof-of-concept","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3265277/0/en/SCYNEXIS-Completes-Transformative-Acquisition-of-PXL-770-an-innovative-highly-selective-direct-AMPK-activator-for-the-Treatment-of-Autosomal-Dominant-Polycystic-Kidney-Disease-ADPK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617569408","title":"Scynexis Reports Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2617569408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617569408?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:20","pubTimestamp":1772659200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUAVCL7K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617038569","title":"Press Release: SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2617038569","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617038569?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:20","pubTimestamp":1772659200,"startTime":"0","endTime":"0","summary":"-- SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling. -- SCYNEXIS announced dosing of the first patient using the intravenous . formulation of SCY-247 in a Phase 1 study and plans to report topline. -- Responding to patients' need for alternatives to existing anti-fungal. therapies, SCYNEXIS plans to initiate an expanded access program for. -- SCYNEXIS ended Q4 2025 with cash, cash equivalents and investments of. $56.3 million, resulting in a cash runway of more than two years. \"In the fourth quarter, we continued to advance our second generation fungerp, SCY-247, and also strengthened our balance sheet with the receipt of $24.8 million from GSK, extending our cash runway for more than two years,\" said David Angulo, M.D., President and Chief Executive Officer. \"Looking ahead, SCYNEXIS remains well positioned to explore a number of opportunities to enhance shareholder value, including releasing Phase 1 data from our SCY-247 intravenous  formulation study later thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VVC","R","BK4532","BK4588","SCYX","BK4232","BK4585","GSKH","GSK","GSK.UK","LU1829250122.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617289566","title":"SCYNEXIS posts FY 2025 license agreement revenue of USD 19.2 million up 411.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617289566","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617289566?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:04","pubTimestamp":1772658247,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SCYNEXIS Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLc6vTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614426940","title":"SCYNEXIS Doses First Participants in Phase 1 IV SCY-247 SAD/MAD Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614426940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614426940?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:23","pubTimestamp":1772112225,"startTime":"0","endTime":"0","summary":"SCYNEXIS Inc. announced that the first participants have been dosed in a Phase 1 single ascending dose and multiple ascending dose clinical trial evaluating an intravenous formulation of its second-generation triterpenoid antifungal candidate SCY-247. The study is assessing IV SCY-247 for development as a treatment for invasive candidiasis and as prophylaxis for invasive fungal disease. Results from this Phase 1 trial are expected to be reported in 2026; results have not yet been presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL4hx3Tn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014021.USD","BK4112","BK4585","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","SCYX","SG9999014005.SGD","SG9999014013.SGD","SG9999014039.USD","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614042699","title":"Scynexis Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous Scy-247","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614042699?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:23","pubTimestamp":1772112209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA4GW1R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614042627","title":"Scynexis Inc: Results From Phase 1 Trial Are Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614042627?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:23","pubTimestamp":1772112209,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA4GW1R2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606671906","title":"SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671906","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671906?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605200,"startTime":"0","endTime":"0","summary":"This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan.  28, 2026  (G","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227560/0/en/SCYNEXIS-Announces-Presentations-Highlighting-the-Potent-Antifungal-Activity-of-its-Second-Generation-Fungerp-SCY-247-Against-Drug-Resistant-Fungi-at-the-Inaugural-Interdisciplinar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVC","IDSA","SCY","BK4007","BK4188","SCYX","ASM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605410229","title":"BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247","url":"https://stock-news.laohu8.com/highlight/detail?id=2605410229","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605410229?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:01","pubTimestamp":1769000519,"startTime":"0","endTime":"0","summary":"BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247Jan 21 (Reuters) - SCYNEXIS Inc SCYX.O:SCYNEXIS RECEIVES FDA QUALIFIED INFECTIOUS DISEASE PRODUC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA45C3JQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}